Renaissance Technologies - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$256
-60.1%
502,600
-50.7%
0.00%
-100.0%
Q1 2023$642
-37.4%
1,019,800
-35.4%
0.00%0.0%
Q4 2022$1,025
-99.8%
1,578,700
+64.4%
0.00%0.0%
Q1 2022$626,000
+13.0%
960,060
+89.0%
0.00%0.0%
Q4 2021$554,000
-79.2%
507,900
-65.3%
0.00%
-66.7%
Q3 2021$2,662,000
+7.3%
1,462,487
+55.6%
0.00%0.0%
Q2 2021$2,482,000
+57.9%
940,200
+115.3%
0.00%
+50.0%
Q1 2021$1,572,000
+1749.4%
436,600
+1197.1%
0.00%
Q4 2020$85,000
-81.8%
33,659
-81.8%
0.00%
Q3 2020$466,000
+179.0%
184,903
+264.2%
0.00%
Q2 2020$167,000
-89.9%
50,763
-92.5%
0.00%
-100.0%
Q1 2020$1,659,000
+2413.6%
677,100
+4712.0%
0.00%
Q4 2019$66,000
-88.2%
14,071
-89.2%
0.00%
Q3 2019$559,000
-53.5%
130,605
-36.7%
0.00%
-100.0%
Q2 2019$1,203,000
+27.7%
206,302
-14.1%
0.00%0.0%
Q2 2018$942,0000.0%240,2570.0%0.00%0.0%
Q1 2018$942,000
-47.0%
240,257
-23.8%
0.00%
-66.7%
Q3 2016$1,776,000
+150.8%
315,457
+17.6%
0.00%
+50.0%
Q3 2014$708,000
+84.4%
268,341
+220.3%
0.00%
+100.0%
Q1 2014$384,00083,7740.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders